Adverse reactions: Summary of the latest adverse reactions of cabozantinib

Cabozantinib (Cabozantinib) is a targeted therapy drug that is commonly used to treat various cancer types such as advanced renal cell carcinoma and thyroid cancer. Although cabozantinib has significant efficacy in treating cancer, it may also cause a range of adverse effects. The following is a summary of common adverse reactions of cabozantinib:

1.Hypertension: Using cabozantinib may cause high blood pressure, and patients may experience symptoms such as headache, dizziness, and blurred vision. Therefore, during the use of cabozantinib, patients need to monitor their blood pressure regularly and adjust their treatment plan according to their doctor's recommendations.

2.Diarrhea: Diarrhea is one of the common adverse reactions of cabozantinib, which may manifest as abdominal discomfort, abdominal pain, diarrhea and other symptoms. Patients should replenish fluids in time when diarrhea occurs, avoid irritating foods, and use antidiarrheal drugs if necessary.

3.Hand-foot syndrome: Hand-foot syndrome is a common skin reaction when using cabozantinib, which manifests as redness, swelling, pain, blistering and other symptoms on the hands and feet. Patients should keep their hands and feet clean and moisturized and avoid prolonged exposure to high temperatures.

4.Proteinuria: Cabozantinib may cause proteinuria, and patients may experience symptoms such as turbid urine and proteinuria during use. If proteinuria occurs, patients should inform their doctor immediately, who may adjust the treatment plan or take other measures.

5.Fatigue: Fatigue is one of the common adverse reactions of cabozantinib. Patients may feel extreme fatigue, weakness, lack of energy, etc. While taking cabozantinib, patients should rest appropriately and maintain good work and rest habits.

6.Dry mouth: Dry mouth is one of the common adverse reactions when using cabozantinib. Patients may feel symptoms such as dry mouth and thirst. Patients should drink plenty of fluids, keep their mouths clean, and avoid irritating foods.

7.Digestive tract discomfort: The use of cabozantinib may cause digestive tract discomfort, and patients may experience nausea, vomiting, stomach discomfort and other symptoms. When experiencing gastrointestinal discomfort, patients should avoid greasy foods, eat divided meals, and follow the doctor's recommendations.

8.Myelosuppression: Cabozantinib may cause bone marrow suppression, manifested by symptoms such as leukopenia, anemia, and thrombocytopenia. Patients should regularly monitor blood routine indicators during use and follow the doctor's recommendations for treatment.

In general, cabozantinib, as a targeted therapy drug, although it plays an important role in the treatment of cancer, may also cause a series of adverse reactions. Patients should pay close attention to changes in their physical condition while using cabozantinib, and promptly inform their doctors of any symptoms of discomfort so that the treatment plan can be adjusted or corresponding countermeasures can be taken in a timely manner.